University of Pennsylvania researchers have achieved a significant breakthrough in the fight against antibiotic resistance, utilizing an artificial intelligence (AI) system named APEX to identify and ...
Researchers have introduced a novel scientific model, dubbed "Cell Annealing," designed to deepen the understanding of cellular aging and rejuvenation processes. Announced by "Dr Singularity" on socia...
Recent high-resolution video footage captured by cell biologist Alex Ritter of RitterLab vividly demonstrates a killer T cell of the immune system actively destroying a monstrous ovarian cancer cell. ...
A recent social media post by "Dr. Shelby" has spotlighted ten biotechnology companies operating at the forefront of scientific innovation, often navigating complex ethical and legal landscapes. The t...
Centivax, a biotechnology firm focused on durable and universal vaccines, has successfully closed an oversubscribed $45 million Series A funding round. The investment was led by Steve Jurvetson's Futu...
The efficacy of plasmapheresis in reversing human biological aging is currently yielding contradictory results in recent clinical trials. While some research indicates a potential acceleration of agin...
QuantumBio Therapeutics, a pioneering firm at the intersection of quantum mechanics and biological research, has announced the successful closure of a $750 million Series D funding round. The signific...
Recent discussions, notably highlighted by physicist and Genomic Prediction co-founder Steve Hsu, underscore the burgeoning market for polygenic embryo screening (PES) within in vitro fertilization (I...
Dr. George Church, a pioneering molecular engineer and Professor of Genetics at Harvard Medical School, has articulated a vision where biotechnology could enable humans to reach "escape velocity" from...
**Seoul, South Korea** – A novel deep learning model, Cancer Drug Response Profile scan (CDRscan), has demonstrated remarkable accuracy, achieving an R² value exceeding 0.84 and an AUROC over 0.98, in...
